NasdaqCM - Nasdaq Real Time Price USD
Moleculin Biotech, Inc. (MBRX)
0.9926
-0.0774
(-7.23%)
As of 12:03:49 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-23,862
-23,862
-23,591
-27,639
-18,951
Investing Cash Flow
-13
-13
-124
-67
-19
Financing Cash Flow
4,635
4,635
4,141
-23
74,724
End Cash Position
4,278
4,278
23,550
43,145
70,903
Income Tax Paid Supplemental Data
--
--
--
--
15
Interest Paid Supplemental Data
--
--
--
--
0
Capital Expenditure
-13
-13
-124
-67
-19
Issuance of Capital Stock
4,660
4,660
4,166
0
74,684
Free Cash Flow
-23,875
-23,875
-23,715
-27,706
-18,970
12/31/2021 - 6/2/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GLMD Galmed Pharmaceuticals Ltd.
1.2796
-0.81%
ZVSA ZyVersa Therapeutics, Inc.
0.4999
-3.49%
PHIO Phio Pharmaceuticals Corp.
1.8600
-2.11%
SPRC SciSparc Ltd.
0.3247
-3.58%
FGEN FibroGen, Inc.
0.3034
+1.37%
PSTV Plus Therapeutics, Inc.
0.7258
+3.98%
ENSC Ensysce Biosciences, Inc.
2.3300
+12.56%
HEPA Hepion Pharmaceuticals, Inc.
0.3180
0.00%
IVVD Invivyd, Inc.
0.8452
-1.82%
APM Aptorum Group Limited
0.9851
+1.92%